Literature DB >> 28991319

[Etiology and evolution of the osteoarticular infections. 2009-2015: Pediatric Hospital Pereira Rossell Uruguay].

Carlos Zuníno1, Alejandra Vomero1, Soledad Pandolfo1, Claudia Gutiérrez2, Gabriela Algorta2, M Catalina Pírez1, Gustavo Giachetto1.   

Abstract

BACKGROUND: The most frequent osteoarticular infections (OAI) etiological agent is Staphylococcus aureus. The prevalence of other microorganisms has changed after the introduction of new vaccines. AIM: To describe the etiology and evolution of the OAIs in children hospitalized in Pediatric Hospital Pereira Rossell between 2009 and 2015. PATIENTS AND METHODS: Joint fluid and bone puncture studies of hospitalized children suspected of OAI. Epidemiological characteristics, isolated microorganisms, complementary tests, initial treatment, complications, and days of hospitalization were analyzed.
RESULTS: 335 patients; the etiology was established in 113. Clinical data could be analyzed in 87 cases. The average age was 6.1 years. They corresponded to: methicillin-sensitive S. aureus (n: 47), community-acquired methicillin-resistant S. aureus (CA-MRSA) (n: 11), Streptococcus pyogenes (n: 6), Streptococcus pneumoniae (n: 1), Haemophilus influenzae type b (n: 2), Gram-negative bacilli (n: 9), Kingella kingae (n: 1) others (n: 6). In 4 cases, more than one microorganism was isolated. CA-MRSA infections were more serious. DISCUSSION: A decrease is observed in the number of CA-MRSA isolates. A fact to be highlighted is the impact of universal vaccination against S. pneumoniae and H. influenzae type b. It is a finding to be monitored the increasing number of Gram-negative bacilli isolates.

Entities:  

Mesh:

Year:  2017        PMID: 28991319     DOI: 10.4067/S0716-10182017000300005

Source DB:  PubMed          Journal:  Rev Chilena Infectol        ISSN: 0716-1018            Impact factor:   0.520


  2 in total

1.  Antimicrobial susceptibility among Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2015 and 2017 as part of the Tigecycline Evaluation and Surveillance Trial (TEST).

Authors:  Zhijie Zhang; Meng Chen; Ying Yu; Sisi Pan; Yong Liu
Journal:  Infect Drug Resist       Date:  2019-05-10       Impact factor: 4.003

Review 2.  Osteoarticular infections in pediatrics.

Authors:  Paula Andrade Alvares; Marcelo Jenné Mimica
Journal:  J Pediatr (Rio J)       Date:  2019-11-26       Impact factor: 2.990

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.